Showing results (1-10 of 224) with videos related to
Sort By:
Pageof 23
Lancet (London, England)|May 3, 2016
Acute respiratory distress syndromeRob Mac Sweeney, Daniel F McAuleySeminars in Respiratory and Critical Care Medicine|October 13, 2011
Acute lung failureRob Mac Sweeney, Daniel F McAuley, Michael A MatthayCritical Care (London, England)|December 24, 2010
Beta 2 antagonism in acute respiratory failureRob Mac Sweeney, P J Devereaux, Daniel F McAuleySeminars in Respiratory and Critical Care Medicine|August 13, 2013
Treatment of acute lung injury: current and emerging pharmacological therapiesRob Mac Sweeney, Mark Griffiths, Danny McAuleyBMC Medicine|August 21, 2013
Pharmacological treatments in ARDS; a state-of-the-art updateAndrew James Boyle, Rob Mac Sweeney, Daniel Francis McAuleyThorax|April 23, 2021
Transepithelial nasal potential difference in patients with, and at risk of acute respiratory distress syndromeRob Mac Sweeney, Kiran Reddy, Jane C Davies, et al.Clinics in Chest Medicine|December 3, 2014
Clinical trial design in prevention and treatment of acute respiratory distress syndromeGerard F Curley, Daniel F McAuleyCurrent Opinion in Anaesthesiology|January 31, 2015
Sedation/drugs used in intensive care sedationValerie J Page, Daniel F McAuleyExpert Opinion on Emerging Drugs|August 26, 2014
Is there a need for emerging drugs for the acute respiratory distress syndrome?Marianne Fitzgerald, Daniel F McAuley, Michael MatthayCritical Care (London, England)|June 7, 2017
Effect sizes in ongoing randomized controlled critical care trialsElliott E Ridgeon, Rinaldo Bellomo, Scott K Aberegg, et al.Pageof 23